S100A9 and hepatocellular carcinoma: To assess whether S100A9 promotes tumorigenesis through a PGAM5‐dependent pathway, stable PGAM5‐overexpressing/knockdown HCC cells were constructed (Figure S5A–C, Supporting Information).